Pyrrol derivatives, preparation and use of the same in therapy

Details for Australian Patent Application No. 2007330651 (hide)

Owner SANOFI-AVENTIS

Inventors Congy, Christian; Hortala, Laurent; Barth, Francis; Rinaldi-Carmona, Murielle

Agent A J Park

Pub. Number AU-A-2007330651

PCT Pub. Number WO2008/068423

Priority 0610202 20.11.06 FR

Filing date 19 November 2007

Wipo publication date 12 June 2008

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/4545 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

C07D 207/06 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/06 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/66 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 317/58 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/068423 Priority application(s): WO2008/068423

4 June 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Pyrrole derivatives, preparation and use of the same in therapy

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007330652-Substituted 2,5-dfflydro-3H-pyrazolo[4,3-C]pyridazi n-3-one derivatives, preparation thereof and use of same as cannabinoid CB1 receptor ligands

2007330647-Salt substitute and composition by food example containing the same<0}